Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 256.53B | 274.39B | 222.43B | 210.81B | 133.82B | 91.31B |
Gross Profit | 71.92B | 73.36B | 69.86B | 72.08B | 48.68B | 30.78B |
EBITDA | 41.28B | 51.63B | 44.59B | 47.85B | 30.76B | 18.82B |
Net Income | 14.30B | 15.69B | 15.15B | 29.70B | 26.66B | 8.28B |
Balance Sheet | ||||||
Total Assets | 565.74B | 600.59B | 510.03B | 410.65B | 264.77B | 177.19B |
Cash, Cash Equivalents and Short-Term Investments | 114.56B | 117.73B | 117.25B | 103.11B | 52.58B | 30.20B |
Total Debt | 159.41B | 168.28B | 140.85B | 72.26B | 39.52B | 49.77B |
Total Liabilities | 268.36B | 277.04B | 231.86B | 161.00B | 103.82B | 98.95B |
Stockholders Equity | 216.19B | 236.83B | 204.41B | 183.77B | 131.07B | 67.18B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -25.17B | -46.51B | -13.95B | -15.99B | -1.08B |
Operating Cash Flow | 0.00 | 26.07B | 28.72B | 43.02B | 17.83B | 13.22B |
Investing Cash Flow | 0.00 | -36.63B | -92.40B | -68.76B | -29.40B | -20.88B |
Financing Cash Flow | 0.00 | 15.97B | 55.24B | 68.72B | 30.60B | 21.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥81.88B | 8.70 | 1.13% | 11.53% | 20.33% | ||
79 Outperform | ¥143.66B | 9.14 | 7.01% | 5.63% | 23.36% | 3.61% | |
72 Outperform | ¥151.79B | 15.69 | 3.68% | 18.61% | 30.56% | ||
71 Outperform | ¥135.90B | 15.19 | 3.43% | 9.00% | -50.84% | ||
69 Neutral | ¥193.82B | 3.79 | 0.38% | -48.30% | ― | ||
63 Neutral | $33.61B | 6.06 | -11.53% | 1.82% | 5.53% | -18.79% |